Author： Judson I.
Publisher： Adis International
ISSN： 0012-6667
Source： Drugs, Vol.63, Iss.5, 2003-01, pp. : 523-524
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Imatinib mesylate promising for CML
Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. :
Access to resources
Recommend
Imatinib mesylate: response in hypereosinophilic syndrome
Inpharma, Vol. 1, Iss. 1381, 2003-01 ,pp. :
Surpassing the success of imatinib mesylate in CML
Inpharma, Vol. 1, Iss. 1385, 2003-01 ,pp. :
Lonafarnib overcomes imatinib mesylate resistance
Inpharma, Vol. 1, Iss. 1357, 2002-01 ,pp. :